Use of pharmacokinetic modeling to design studies for pathway-specific exposure model evaluation
Validating an exposure pathway model is difficult because the biomarker, which is often used to evaluate the model prediction, is an integrated measure for exposures from all the exposure routes and pathways. The purpose of this article is to demonstrate a method to use pharmacokinetic (PK) modeling and computer simulation to guide the design of field studies to validate pathway models. The children's dietary intake model is discussed in detail as an example. Three important aspects are identified for a successful design to evaluate the children's dietary intake model: a) longitudinally designed study with significant changes in the exposure for the route/pathway of interest, b) short biologic half-life of the selected chemical, and c) surface loading of the selected chemical at sufficient levels. Using PK modeling to guide a study design allowed a path-specific exposure model to be evaluated using urinary metabolite biomarkers
Hu, Y., Akland, G., Pellizzari, E., Berry, M. R., & Melnyk, L. J. (2004). Use of pharmacokinetic modeling to design studies for pathway-specific exposure model evaluation. Environmental Health Perspectives, 112(17), 1697-1703.